Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil
- PMID: 7202473
- DOI: 10.1007/BF00568400
Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil
Abstract
Following i.v. administration, the plasma concentration-time curve of verapamil could best be described by either a mono- or biexponential equation. Total plasma clearance (1.26 1/min) approached liver blood flow (1.51/min), so it can be concluded that its clearance is liver blood flow-dependent. Although absorption was almost complete after oral administration, absolute bioavailability (20%) was low, due to extensive hepatic first-pass metabolism. The approach using stable isotope-labelled and unlabelled drug permits simultaneous administration by the intravascular and extravascular routes, thus allowing determination of absolute bioavailability in a single experiment.
Similar articles
-
Clinical pharmacokinetics of verapamil.Clin Pharmacokinet. 1984 Jan-Feb;9(1):26-41. doi: 10.2165/00003088-198409010-00002. Clin Pharmacokinet. 1984. PMID: 6362951 Review.
-
Superiority of stable isotope techniques in the assessment of the bioavailability of drugs undergoing extensive first pass elimination. Studies of the relative bioavailability of verapamil tablets.Eur J Clin Pharmacol. 1981 Jan;19(2):127-31. doi: 10.1007/BF00568399. Eur J Clin Pharmacol. 1981. PMID: 7202472
-
Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.Hepatology. 1996 Oct;24(4):796-801. doi: 10.1002/hep.510240407. Hepatology. 1996. PMID: 8855178
-
Physiological disposition of verapamil in man.Cardiovasc Res. 1976 Sep;10(5):605-12. doi: 10.1093/cvr/10.5.605. Cardiovasc Res. 1976. PMID: 971476
-
Calcium antagonists. Pharmacokinetic properties.Drugs. 1983 Feb;25(2):113-24. doi: 10.2165/00003495-198325020-00002. Drugs. 1983. PMID: 6339196 Review.
Cited by
-
New antiarrhythmic drugs: their place in therapy.Drugs. 1981 Nov;22(5):363-400. doi: 10.2165/00003495-198122050-00002. Drugs. 1981. PMID: 6800757 Review. No abstract available.
-
Clinical pharmacokinetics of verapamil.Clin Pharmacokinet. 1984 Jan-Feb;9(1):26-41. doi: 10.2165/00003088-198409010-00002. Clin Pharmacokinet. 1984. PMID: 6362951 Review.
-
Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.Br J Clin Pharmacol. 1984 Nov;18(5):733-40. doi: 10.1111/j.1365-2125.1984.tb02536.x. Br J Clin Pharmacol. 1984. PMID: 6508982 Free PMC article.
-
Validation of the hepatic blood flow rate model for verapamil first-pass metabolism.Eur J Drug Metab Pharmacokinet. 2007 Jan-Mar;32(1):13-9. doi: 10.1007/BF03190985. Eur J Drug Metab Pharmacokinet. 2007. PMID: 17479539 Clinical Trial.
-
Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.Br J Clin Pharmacol. 1983 Dec;16(6):669-75. doi: 10.1111/j.1365-2125.1983.tb02239.x. Br J Clin Pharmacol. 1983. PMID: 6661352 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources